Market reference note: This article covers information from both Korea and the United States. Each piece of information is labeled in the text with 🇰🇷 Korea or 🇺🇸 U.S. to indicate which country it applies to.
When a dementia diagnosis is received, the entire family can feel lost. Many people walk out of the hospital with a diagnosis in hand and have no idea what to do next. Yet there are programs that only become available after a diagnosis is made. How well you make use of these programs at this stage has a far greater impact on long-term caregiving than anything available during the screening phase.
🇰🇷 Korea According to the 2023 치매역학조사 (National Dementia Epidemiological Survey) conducted by the 보건복지부 (Ministry of Health and Welfare) and the 중앙치매센터 (Central Dementia Center), the number of dementia patients in Korea is estimated to exceed 1 million by 2026. Among adults aged 65 and older, the prevalence of dementia is 9.25%, and the prevalence of mild cognitive impairment — which carries a high risk of progressing to dementia — stands at 28.42%. As these numbers show, dementia has become a challenge that society as a whole must prepare for, not just individual families.
🇰🇷 Korea Seniors who have received a dementia diagnosis can register as a 치매 환자 (dementia patient) at the 치매안심센터 (Dementia Relief Center) of the 보건소 (public health center) that covers their registered address. To register, you must bring a diagnosis certificate, a prescription, and a copy of a bank account held in the patient's name. Once registration is complete, services tailored to the individual are connected, including one-on-one case management, access to 치매 쉼터 (dementia daycare lounges), and provision of 조호물품 (caregiving supplies). Because the assigned case manager will guide you through service changes whenever the patient's condition shifts, family caregivers no longer need to search for all the information on their own.
🇰🇷 Korea After registration, support for treatment management costs is also available. For households at or below 140% of the standard median income (up to 120% depending on the local government), out-of-pocket medical and medication costs for dementia treatment are reimbursed on an actual-expense basis, up to a maximum of 30,000 won per month and 360,000 won per year. Once registered, you can apply every month, which provides ongoing relief from the cost of dementia medications that require long-term use. The 치매안심센터 also connects patients with wandering prevention services, including 배회감지기 (wandering detection devices), 인식표 (ID tags), and fingerprint registration.
🇰🇷 Korea Support is also available before a formal diagnosis, during the screening stage. Anyone aged 60 or older can receive a free 인지선별검사 (cognitive screening test) at a 치매안심센터 regardless of income. If the screening reveals signs of cognitive decline, support is also provided for diagnostic testing costs at affiliated hospitals (up to 150,000 won) and for differential diagnostic testing costs (up to 80,000 won at clinics and general hospitals, up to 110,000 won at tertiary hospitals). One important point: you must visit the 치매안심센터 first before undergoing any testing to confirm the support process. If you proceed with testing without prior approval, you may be excluded from eligibility, so be sure to follow the correct order of steps.
🇺🇸 U.S. In the United States, Medicare enrollees can receive a cognitive function assessment through the Annual Wellness Visit, which is provided free of charge once per year. This visit is available at no cost to those who have maintained Medicare Part B for 12 months or more, and a cognitive function assessment is included as a required component. If any warning signs are identified during the visit, Medicare provides additional coverage for a separate, more detailed cognitive assessment visit.
🇺🇸 U.S. After receiving a dementia diagnosis, patients can take advantage of the GUIDE (Guiding an Improved Dementia Experience) program. This program is available to patients enrolled in Medicare Part A and Part B (Original Medicare), launched in July 2024, and will run through 2032. It offers care coordination, a 24-hour support helpline, family caregiver education, and up to 2,500 dollars per year in respite care — all at no additional cost. However, Medicare Advantage enrollees, nursing home residents, and hospice beneficiaries are excluded from eligibility.
In both Korea and the United States, the doors to these programs are open — but you have to knock on them yourself. The fastest way to get started is to ask your 치매안심센터 or primary care physician about the next steps on the very day you receive your diagnosis. If you are not sure where to begin, Sierra Care Advisor is here to help you navigate the programs available in both Korea and the United States.
Sources: 보건복지부 (Ministry of Health and Welfare) 2023 치매역학조사 (National Dementia Epidemiological Survey) and 실태조사 (Status Survey) results / 중앙치매센터 (Central Dementia Center) / 복지로 (보건복지부 치매검사비 지원사업 안내 (Ministry of Health and Welfare Dementia Testing Cost Support Program Guide), 2026) / CMS GUIDE Model official guidance (Centers for Medicare & Medicaid Services) / Medicare.gov cognitive function assessment and care plan services guidance / benefitsusa.org, helpdementia.com (based on 2026 standards)
Note: This article was compiled by AI from the sources cited above. We strive for accuracy, but for decisions about your specific situation, please confirm the latest guidance from a professional or the relevant agency.